Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 study evaluating resiniferatoxin for knee osteoarthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Resiniferatoxin (resiniferatoxin)

Snippet

Sponsor: Sorrento Therapeutics, Inc. | Conditions: Osteoarthritis, Knee, Knee Pain Chronic | Phase 3 | Status: WITHDRAWN